Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Ho

Showing results (241-250 of 321) with videos related to

Pageof 33
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomasB Wiedenmann, P Reichardt, U Räth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2010
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group studyM Rieger, A Österborg, R Pettengell, et al.
Bone Marrow Transplantation|July 15, 2009
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patientsS Fruehauf, G Ehninger, K Hübel, et al.
Leukemia Research|January 1, 1990
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsivenessC Weiss, A D Ho, E Hiller, et al.
Bone Marrow Transplantation|June 27, 2017
Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHDM Zeisbrich, N Becker, A Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic siteM Körbling, R Holle, R Haas, et al.
Seminars in Oncology|December 1, 1990
Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphomaA D Ho, F Del Valle, R Haas, et al.
Leukemia|April 1, 1987
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomyH Pralle, T Zwingers, S Boedewadt, et al.
Onkologie|February 1, 1987
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]H Pralle, T Zwingers, S Boedewadt, et al.
Blood|November 1, 1989
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemiaM Körbling, W Hunstein, T M Fliedner, et al.
Pageof 33

Showing results (241-250 of 321) with videos related to

Sort By:
Pageof 33
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomasB Wiedenmann, P Reichardt, U Räth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2010
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group studyM Rieger, A Österborg, R Pettengell, et al.
Bone Marrow Transplantation|July 15, 2009
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patientsS Fruehauf, G Ehninger, K Hübel, et al.
Leukemia Research|January 1, 1990
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsivenessC Weiss, A D Ho, E Hiller, et al.
Bone Marrow Transplantation|June 27, 2017
Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHDM Zeisbrich, N Becker, A Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic siteM Körbling, R Holle, R Haas, et al.
Seminars in Oncology|December 1, 1990
Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphomaA D Ho, F Del Valle, R Haas, et al.
Leukemia|April 1, 1987
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomyH Pralle, T Zwingers, S Boedewadt, et al.
Onkologie|February 1, 1987
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]H Pralle, T Zwingers, S Boedewadt, et al.
Blood|November 1, 1989
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemiaM Körbling, W Hunstein, T M Fliedner, et al.
Pageof 33